</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
CB Partner Webinar 1 hour PetDx {{webinarsautomatedemailsregistrationconfirmation::client_only_logo}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_self_hosted}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_alt}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_width}} {{webinarsautomatedemailsregistrationconfirmation::client_only_logo_custom_css}} {{webinarsautomatedemailsregistrationconfirmation::client_color}} {{webinarsautomatedemailsregistrationconfirmation::supported_by}} This webinar will provide an overview of how next-generation sequencing can be used to detect cancer-associated genomic alterations in the blood of dogs. Define “liquid biopsy” and examine how next-generation sequencing can be used to identify cancer-associated genomic alterations in the blood of dogs. Review test performance metrics such as sensitivity and specificity and determine positive and negative predictive values to better understand your patient’s liquid biopsy results. Identify real-world opportunities for liquid biopsy incorporation into routine wellness examinations or as an aid in diagnosis when cancer is on the differential diagnoses list. {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_4}} {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_5}} {{webinarsautomatedemailsregistrationconfirmation::learning_objectives_bullet_6}}
Dear #FIRSTNAME#,
Thank you for registering for "#EVENTTITLE#," sponsored by PetDx. Thank you for registering for "#EVENTTITLE#."
This webinar will provide an overview of how next-generation sequencing can be used to detect cancer-associated genomic alterations in the blood of dogs.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Learning Objectives
  • Define “liquid biopsy” and examine how next-generation sequencing can be used to identify cancer-associated genomic alterations in the blood of dogs.
  • Review test performance metrics such as sensitivity and specificity and determine positive and negative predictive values to better understand your patient’s liquid biopsy results.
  • Identify real-world opportunities for liquid biopsy incorporation into routine wellness examinations or as an aid in diagnosis when cancer is on the differential diagnoses list.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Webinar Details
#EVENTDAY#, #EVENTDATE#  |  #EVENTTIME# #EVENTTIMEZONESHORT#  |  1 hour
Sponsored by PetDx
Add to Your Calendar
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
#CALENDARREMINDER#
How to Join the Webinar
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
#AUDIENCEURL#
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
Thank you for registering! We look forward to seeing you.
Sincerely,
The Clinician's Brief Team
The PetDx Team
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
Dear #FIRSTNAME#,
Thank you for registering for "#EVENTTITLE#," sponsored by PetDx. Thank you for registering for "#EVENTTITLE#."
This webinar will provide an overview of how next-generation sequencing can be used to detect cancer-associated genomic alterations in the blood of dogs.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Learning Objectives
  • Define “liquid biopsy” and examine how next-generation sequencing can be used to identify cancer-associated genomic alterations in the blood of dogs.
  • Review test performance metrics such as sensitivity and specificity and determine positive and negative predictive values to better understand your patient’s liquid biopsy results.
  • Identify real-world opportunities for liquid biopsy incorporation into routine wellness examinations or as an aid in diagnosis when cancer is on the differential diagnoses list.
If you have any questions for our speaker, you can direct them to support@cliniciansbriefhelp.zendesk.com
Webinar Details
#EVENTDAY#, #EVENTDATE#  |  #EVENTTIME# #EVENTTIMEZONESHORT#  |  1 hour
Sponsored by PetDx
Add to Your Calendar
Use the links below to add to your calendar. We'll also send a couple reminders in advance of the webinar.
#CALENDARREMINDER#
How to Join the Webinar
Click the link below to join the webinar. You can join up to 15 minutes before the start time.
#AUDIENCEURL#
Once you click the link, you may be prompted to sign in with the email you used to register (#EMAIL#).
Thank you for registering! We look forward to seeing you.
Sincerely,
The Clinician's Brief Team
The PetDx Team